The research project is investigating a new potential treatment for auto-immune diseases (where your own immune system attacks healthy organs and cells by mistake). The study drug being investigated is called HL161BKN.
Phase 1
- Conditions
- Auto-Immune Diseases
- Registration Number
- ACTRN12618001502224
- Lead Sponsor
- IQVIA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method